Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Rapport Therapeutics, Inc. (RAPP) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Rapport Therapeutics, Inc. (RAPP) on November 10, 2026 is 25.96 $, −0.42 % on the day. Over 52 weeks the stock traded between 22.06 $ and 52.93 $; the price now sits 13 % of the way up that range. Over the past year the price changed by +4.19 %. Market capitalization is 1.24 billion $, rank 108 among 379 stocks of the same industry with a known capitalization.
Rapport Therapeutics, Inc. trades on Nasdaq under the ticker RAPP. The company belongs to the Health care sector. The trading history on this page starts on 7 June 2024.
Over the past 52 weeks RAPP has traded between 22.06 $ and 52.93 $. As of 10 November 2026 the price stood 12.63% of the way from the 52-week low to the high.
Over one year RAPP shares rose 4.19%; over six months they fell 30.29%. Volatility over 90 days is 75.73%. Dividends are not included: this is price change only, as of 10 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 2.9, above the sector median of 2.3. Calculated from reports for the period ending 30 June 2026.
RAPP has a return on equity of −32.43%, above the sector median of −40.58%. Return on assets is −29.88%, above the sector median of −30.08%.